×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RMD – resmed inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/15
07:02 pm
rmd
Reflecting On Patient Monitoring Stocks' Q3 Earnings: ResMed (NYSE:RMD) [Yahoo! Finance]
Low
Report
Reflecting On Patient Monitoring Stocks' Q3 Earnings: ResMed (NYSE:RMD) [Yahoo! Finance]
1/13
09:18 am
rmd
A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]
Low
Report
A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]
1/8
04:05 pm
rmd
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Low
Report
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
1/8
09:23 am
rmd
An excellent week for ResMed Inc.'s (NYSE:RMD) institutional owners who own 69% as one-year returns inch higher [Yahoo! Finance]
Low
Report
An excellent week for ResMed Inc.'s (NYSE:RMD) institutional owners who own 69% as one-year returns inch higher [Yahoo! Finance]
1/1
06:03 am
rmd
Here's What ResMed's (NYSE:RMD) Strong Returns On Capital Mean [Yahoo! Finance]
Low
Report
Here's What ResMed's (NYSE:RMD) Strong Returns On Capital Mean [Yahoo! Finance]
12/30
04:14 pm
rmd
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.
12/18
04:05 pm
rmd
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
12/18
08:03 am
rmd
ResMed (NYSE:RMD) was given a new $260.00 price target on by analysts at Stifel Nicolaus. They now have a "hold" rating on the stock.
Low
Report
ResMed (NYSE:RMD) was given a new $260.00 price target on by analysts at Stifel Nicolaus. They now have a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/9
07:33 am
rmd
Form 4 RESMED INC For: Jan 07 Filed by: FARRELL PETER C
Low
Report
Form 4 RESMED INC For: Jan 07 Filed by: FARRELL PETER C
1/8
03:24 pm
rmd
Form 4 RESMED INC For: Jan 07 Filed by: Farrell Michael J.
Low
Report
Form 4 RESMED INC For: Jan 07 Filed by: Farrell Michael J.
1/7
05:03 pm
rmd
Form 144 RESMED INC Filed by: FARRELL PETER C
Low
Report
Form 144 RESMED INC Filed by: FARRELL PETER C
1/7
04:17 pm
rmd
Form 144 RESMED INC Filed by: Farrell Michael J.
Low
Report
Form 144 RESMED INC Filed by: Farrell Michael J.
1/5
05:27 pm
rmd
Form 4 RESMED INC For: Jan 02 Filed by: Sandercock Brett
Low
Report
Form 4 RESMED INC For: Jan 02 Filed by: Sandercock Brett
1/5
01:18 pm
rmd
Form 4 RESMED INC For: Jan 02 Filed by: Rider Michael J
Low
Report
Form 4 RESMED INC For: Jan 02 Filed by: Rider Michael J
1/2
12:45 pm
rmd
Form 144 RESMED INC Filed by: Sandercock Brett
Low
Report
Form 144 RESMED INC Filed by: Sandercock Brett
1/2
10:56 am
rmd
Form 144 RESMED INC Filed by: Rider Michael J
Low
Report
Form 144 RESMED INC Filed by: Rider Michael J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/24
Q1/2020 9/30/2019 EPS 0.930 ZacksConsensus 0.870 ActVsEst 0.060 - Beat
12.9%
3/23 ResMed Statement on COVID-19 11.3%
3/26 ResMed Inc. (NYSE: RMD) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. 8.5%
3/3 Form 4 RESMED INC For: Mar 02 Filed by: Hollingshead James 7.4%
3/21 INSIGHT-Army joins the production line as ventilator makers scramble to meet demand [Reuters] 6.2%
4/1 Tesla could help make batteries for ventilators to help fight COVID-19, says ResMed CEO [CNBC] 4.7%
4/3 Form 4 RESMED INC For: Apr 02 Filed by: Hollingshead James 3.5%
4/2 ResMed Statement on DPA 2.7%
2/3 ResMed Inc. (NYSE: RMD) is now covered by analysts at CLSA. They set an "underperform" rating on the stock. 2.6%
7/25 Q4/2019 6/30/2019 EPS 0.950 ZacksConsensus 0.920 ActVsEst 0.030 - Beat 2.4%
3/23 ResMed Statement on COVID-19 11.3%
3/26 ResMed Inc. (NYSE: RMD) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. 8.5%
3/3 Form 4 RESMED INC For: Mar 02 Filed by: Hollingshead James 7.4%
3/21 INSIGHT-Army joins the production line as ventilator makers scramble to meet demand [Reuters] 6.2%
4/1 Tesla could help make batteries for ventilators to help fight COVID-19, says ResMed CEO [CNBC] 4.7%
4/3 Form 4 RESMED INC For: Apr 02 Filed by: Hollingshead James 3.5%
4/2 ResMed Statement on DPA 2.7%
2/3 ResMed Inc. (NYSE: RMD) is now covered by analysts at CLSA. They set an "underperform" rating on the stock. 2.6%
7/25 Q4/2019 6/30/2019 EPS 0.950 ZacksConsensus 0.920 ActVsEst 0.030 - Beat 2.4%
TOP News Decliners
3/19
Why COVID-19 News Caused ResMed Shares to Tumble 10.3% Today [The Motley Fool]
-16.0%
1/30 Resmed Inc (RMD) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
3/17 Form 4 RESMED INC For: Mar 16 Filed by: Douglas Robert Andrew -5.7%
5/1 ResMed Inc. (NYSE: RMD) was upgraded by analysts at Oppenheimer Holdings Inc. to a "buy" rating. They now have a $200.00 price target on the stock. -3.6%
4/29 ResMed Q3 2020 Earnings Preview [Seeking Alpha] -2.7%
4/21 Even After Growth, ResMed Has Plenty of Room to Run [The Motley Fool] -2.5%
3/5 Australia shares mark best day in 2 months on Wall Street lead; NZ up [Reuters] -2.3%
11/20 Form 4 RESMED INC For: Nov 18 Filed by: Douglas Robert Andrew -2.2%
4/16 Form 4 RESMED INC For: Apr 15 Filed by: Douglas Robert Andrew -2.1%
2/27 Obalon Therapeutics down 13% premarket on Q4 results [Seeking Alpha] -2.0%
1/30 Resmed Inc (RMD) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
3/17 Form 4 RESMED INC For: Mar 16 Filed by: Douglas Robert Andrew -5.7%
5/1 ResMed Inc. (NYSE: RMD) was upgraded by analysts at Oppenheimer Holdings Inc. to a "buy" rating. They now have a $200.00 price target on the stock. -3.6%
4/29 ResMed Q3 2020 Earnings Preview [Seeking Alpha] -2.7%
4/21 Even After Growth, ResMed Has Plenty of Room to Run [The Motley Fool] -2.5%
3/5 Australia shares mark best day in 2 months on Wall Street lead; NZ up [Reuters] -2.3%
11/20 Form 4 RESMED INC For: Nov 18 Filed by: Douglas Robert Andrew -2.2%
4/16 Form 4 RESMED INC For: Apr 15 Filed by: Douglas Robert Andrew -2.1%
2/27 Obalon Therapeutics down 13% premarket on Q4 results [Seeking Alpha] -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: